About Solici
As the competitive intelligence arm of Cambridge Healthcare Research, Solici partners with many of the world’s largest pharmaceutical companies to aid in bringing drugs to market. Solici supports the entire drug development lifecycle, from early-stage asset development to clinical trials and lifecycle management. The company operates across numerous disease areas, including rare diseases, oncology, and infectious diseases.
Solici’s mission is to equip its life sciences clients with critical commercial intelligence and strategic insights. Leadership views the company’s value proposition as its ability to sift through noise and extract subtle, meaningful insights that others miss. This human-led approach, combined with the robust clinical and scientific knowledge of its expert teams, ensures that Solici’s clients receive strategic, actionable insights that solve their most pressing problems.
Solici works as a trusted partner to a majority of large pharmaceutical companies globally. Our role is to help them bring their life-changing medicines to market. We do that by supporting these clients with insights and information, answering their questions, and giving them the strategic intelligence needed to bring their products to market.
Solici has long partnered with AlphaSense to bring this vision to life, but until recently, only a limited number of employees had access to the platform.
The Challenge
To maintain its competitive edge and ensure timely delivery of strategic insights, especially during high-pressure periods like earnings season, Solici sought to proactively optimize its data retrieval workflows.
While a few key analysts were utilizing AlphaSense, the lack of a fully centralized intelligence platform meant searches were manually compiled through multiple data sources by the team. Waiting for key transcripts regarding a point of clarification from an earnings call could also result in delays and bottlenecks.
Key Pain Points
- Information bottleneck: Only a small number of employees had AlphaSense licenses, creating a bottleneck for information retrieval.
- Obstructed workflows: Manual note-taking and waiting for transcripts of key events delayed delivery of critical insights.
- Client pressure: In fast-moving markets, delays in intelligence can put clients at a disadvantage. Solici sought to eliminate this risk by accelerating delivery.
- Wasted resources: Time spent manually gathering data was time not spent on high-value strategic analysis.
Our clients like to be informed as soon as something happens. If we become the bottleneck for them, our clients are unhappy. By having that information in real time, we're able to report that to our clients in near-real time. Clients trust us to be ahead of the game and keep them informed so that they, in turn, are credible to their own clients.
The Solution
Solici’s leadership envisions the company as much more than an information provider. The firm needs to generate thoughtful insights that help clients understand their competitive environment and solve for the hurdles they face in their own commercial or clinical businesses. For John’s team, this meant finding a way to streamline the data collection process for every analyst.
Instead of attempting to build a complex, internal system to aggregate the vast and dispersed data sources required for its work, Solici made the strategic decision to expand its partnership with AlphaSense. While a handful of employees previously had platform access, now “the majority of people in the company have an AlphaSense license.” For a company with over 100 analysts, associates and consultants this move exponentially sped up insight generation.
By providing a one-stop shop where all essential information is available in a single, user-friendly space, AlphaSense allows Solici’s teams to access data easily and intuitively. Doubling down on AlphaSense enabled Solici to bypass a costly and time-consuming internal project while leveraging a platform already trusted by its most senior analysts.
The AlphaSense platform combines an ever-expanding suite of content — from scientific publications and regulatory documents to patents and financial reports — with the market’s most powerful AI tools, all in one place. This allows analysts to conduct comprehensive searches and unlock insights needed for obtaining a competitive edge. By having a tool that handles the information-gathering, Solici can focus on its core strength: applying human intelligence to generate strategic insights.
The Results
Through its wider implementation of AlphaSense, Solici now has a powerful tool that transforms research workflows. AlphaSense has revamped the research process by providing a comprehensive, single-source information hub that is now widely accessible across the organization. The platform’s ability to provide real-time transcription services for events like earnings calls has been a game-changer, eliminating the need for manual note-taking and the long wait for official transcripts. This has enabled the team to better capture, analyze, and deliver key insights to clients.
By widely distributing AlphaSense licenses across the company, Solici has unlocked the following key benefits:
- Elevated expertise: AlphaSense provides teams with a single source to rapidly upskill on new topics, ensuring they are always armed with the most up-to-date knowledge for credible conversations.
- Enhanced credibility: By consistently delivering timely, detailed, and accurate insights, Solici has significantly increased client trust, leading to 10+ year client retention rates and a reputation as a trusted thought partner.
- Strategic focus: AlphaSense automates manual research tasks, allowing analysts to reallocate eight hours per week from low-value tasks to high-value strategic client work, fulfilling the company's mission to provide the "so what."
- Competitive edge: The ability to quickly find and report on key insights allows Solici and its clients to get ahead of the competition and act on new developments.
In life sciences, we live in a world that is rapidly changing and evolving, meaning our team needs to be constantly up-to-date on the latest thoughts and opinions across a wide variety of disease classes. AlphaSense provides a place where our teams can go to rapidly upskill themselves — and consequently, when they then have conversations with clients, they can lean on that credibility and that security.
The Future
As Solici continues to grow, its strategic goal is to leverage its expertise to reach an even greater number of clients, proving the value of working with a company that moves beyond basic information delivery to providing tailored, impactful strategic guidance. John sees AlphaSense as “a key tool in giving us the confidence and the information to be able to do that.”
As John explains, the future of competitive intelligence lies not in the data itself, but in the analysis of that data:
The amount of information that we see today is just going to get greater. The true value lies in really analysing and understanding those disparate information sources and extracting what's most important to our client. If you're spending time still manually sifting through those information sources, then you're not spending that time carrying out that value add of analysis and strategic implication. And that's really a missed opportunity.
Building on its success with AlphaSense, the team is now leaning into the platform’s newly expanded Financial Data offering. Early results are already reshaping workflows: By consolidating financials, KPIs, valuations, and qualitative intelligence in one trusted space, Solici is eliminating the tab-hopping and manual stitching that often slow analysts down.
As someone leading multiple client projects, I can say that speed and depth of insight are critical. AlphaSense Financial Data allows me to evaluate companies and sectors holistically, through financials, KPIs, and context, which are all right there in one place. Instead of spending hours piecing things together, I can focus on connecting the dots for clients and delivering implications that drive their strategies forward.
When we’re analyzing comps or entering a new therapeutic area, having financial data and market intelligence unified in AlphaSense makes a real difference. I no longer have to jump between spreadsheets, transcripts, and external tools. I can get a complete, trusted picture in minutes. That efficiency frees me to dig deeper into valuation drivers and highlight the opportunities that matter most to our clients.
By continuing to capture and consolidate information automatically, AlphaSense will allow Solici to scale its operations while ensuring its expert analysts can stay focused on what matters most — delivering strategic value.
Where We’re Going Together
Leveling up financial data: AlphaSense’s newly expanded Financial Data offering is designed to eliminate the guesswork from market research with the most comprehensive intelligence workflow for M&A transactions, industry comps, and more — centralized in one unified platform.
Shifting from aggregation to analysis: Solici recognizes that information itself is becoming a commodity. The firm will rely on AlphaSense to handle the efficient capture and consolidation of that information while its expert teams focus on high-value strategic analysis.
Amplifying insights: As Solici scales and reaches even more clients, the company will lean on AlphaSense as an insights amplifier, powering up its human analysts and streamlining research workflows.
Building a foundation for continued growth: By using AlphaSense as a key tool for information access and intelligence, Solici is future-proofing its business model. The platform gives the company the confidence to grow its services and reinforce its reputation as a trusted thought partner in a constantly evolving market.
